Skip to content
Clinical Trials – home

Klinikum Bayreuth GmbH

Verifiedinfo

Germany Hohe Warte 8, Gruener Baum, 95445 Bayreuth, Germany

  • 17 trials recruiting
  • Dementia Alzheimer's type · Breast cancer · Colorectal cancer metastatic
  • Adult patients

About Specializations

Klinikum Bayreuth GmbH in Bayreuth, Germany specialises in clinical trials of conditions such as Dementia Alzheimer's type, Breast cancer, Colorectal cancer metastatic, Relapsing multiple sclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases

The Neurology department at Klinikum Bayreuth conducts research on neurodegenerative and inflammatory disorders of the central nervous system, seeking to advance treatment options for patients.

  • Mild Cognitive Impairment due to Alzheimer's Disease
  • Alzheimer's Disease Dementia
  • Relapsing Forms of Multiple Sclerosis
  • Progressive Multiple Sclerosis

With four active studies and eight investigators, the site evaluates new therapies for cognitive decline and multiple sclerosis, aiming to improve safety, tolerability, and disease‑modifying outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Hohe Warte 8, Gruener Baum95445 BayreuthGermany
Recruiting now
17 trials
Conditions studied
39
Partner status
Verified

More sites in BayreuthGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

39 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:VHB937
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sargramostim
  • Sponsor:Greenwich LifeSciences Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept
  • Sponsor:Takeda Development Center Americas Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:MALIC ACID
  • Sponsor:Universitaet Muenster
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Stemline Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:FRUQUINTINIB
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:SODIUM DIHYDROGEN PHOSPHATE
  • Sponsor:Athenstaedt GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept
  • Sponsor:Takeda Development Center Americas Inc.
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Blinatumomab
  • Sponsor:Goethe University Frankfurt
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Charite Universitaetsmedizin Berlin KöR
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.